Skip to main content
. 2010 Jun 28;28(27):4255–4267. doi: 10.1200/JCO.2009.25.7816

Fig 1.

Fig 1.

Phenotypic effect size and frequency of occurrence. (*) Named genes only reflect the most likely candidate genes to be implicated by the marker single nucleotide polymorphisms (SNPs) identified from the genome-wide association studies. (†) The marker SNPs mapping to JAK2 in myeloproliferative neoplasms and KITLG in testicular germ cell tumors have odds ratios of approximately 3.0, with allele frequencies ranging from 20% to 40%.

HHS Vulnerability Disclosure